RT Journal Article
T1 Rotavirus gastroenteritis hospitalizations in provinces with different vaccination coverage rates in Spain, 2013-2018
A1 Ruiz-Contreras, J.
A1 Alfayate-Miguelez, S.
A1 Carazo-Gallego, B.
A1 Onis, E.
A1 Diaz-Munilla, L.
A1 Mendizabal, M.
A1 Hernandez, M. Mendez
A1 Ferrer-Lorente, B.
A1 Unsain-Mancisidor, M.
A1 Ramos-Amador, J. T.
A1 Croche-Santander, B.
A1 Malfaz, F. Centeno
A1 Rodriguez-Suarez, J.
A1 Cotarelo, M.
A1 San-Martin, M.
A1 Aristegui, J.
K1 Rotavirus
K1 Acute Gastroenteritis
K1 Hospitalization
K1 Vaccination coverage rate
K1 Spain
K1 Infection
K1 Burden
K1 Vaccines
K1 Children
K1 Surveillance
K1 Europe
K1 Period
K1 Impact
AB Background Rotavirus (RV) vaccines are available in Spain since 2006 but are not included in the National Immunization Program. RV vaccination has reached an intermediate vaccination coverage rate (VCR) but with substantial differences between provinces. The aim of this study was to assess the ratio of RV gastroenteritis (RVGE) admissions to all-cause hospitalizations in children under 5 years of age in areas with different VCR. Methods Observational, multicenter, cross-sectional, medical record-based study. All children admitted to the study hospitals with a RVGE confirmed diagnosis during a 5-year period were selected. The annual ratio of RVGE to the total number of all-cause hospitalizations in children  60%) VCR. Results From June 2013 to May 2018, data from 1731 RVGE hospitalizations (16.47% of which were nosocomial) were collected from the 12 study hospitals. RVGE hospital admissions accounted for 2.82% (95 CI 2.72-3.00) and 43.84% (95% CI 40.53-47.21) of all-cause and Acute Gastroenteritis (AGE) hospitalizations in children under 5 years of age, respectively. The likelihood of hospitalization due to RVGE was 56% (IC95%, 51-61%) and 27% (IC95%, 18-35%) lower in areas with high and intermediate VCR, respectively, compared to the low VCR areas. Conclusions RVGE hospitalization ratios are highly dependent on the RV VCR. Increasing VCR in areas with intermediate and low coverage rates would significantly reduce the severe burden of RVGE that requires hospital management in Spain. Clinical trial registration Not applicable
PB Bmc
YR 2021
FD 2021-11-06
LK https://hdl.handle.net/10668/26557
UL https://hdl.handle.net/10668/26557
LA en
DS RISalud
RD Apr 4, 2025